VOice-guided AI Cancer Evaluation (VOICE) Study

VOice-guided AI Cancer Evaluation (VOICE) Study - VOice-guided AI Cancer Evaluation (VOICE) Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049417

Enrollment

300

Registered

2022-11-02

Start date

2021-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients over 18 years of age at the time of enrollment; 2. patients with histologically diagnosed or suspected cancer 3. patients with lesions in the lower respiratory tract 4. patients who have given written informed consent to participate in this study. If the patient is a minor, the consent of a surrogate (parent or legal guardian) must be obtained.

Exclusion criteria

Exclusion criteria: Patients deemed inappropriate by the principal investigator or subinvestigator

Design outcomes

Primary

Measure	Time frame
Developing a platform for voice-activated cancer diagnosis	—

Countries

Japan

Contacts

Public ContactAkiko Tateishi

National Cancer Center Hospital, Japan Thoracic Oncology Department

atateish@ncc.go.jp03-3542-2511

Outcome results